Healthcare Business
Investors have flocked to the dividends of Big Pharma and flocked to the limitless upside of major biotech outfits for years. Valuations are no longer considered high for these two healthcare...
11 days ago
Last Updated: 11 days ago
Johnson & Johnson has announced that it will launch its human study for its lead vaccine candidate in the United States and Belgium.
11 days ago
Edesa Biotech joins the list of COVID-19 stocks, as the company is making headway with regulatory agencies for its late-stage study. Investors were quick to give this firm the coronavirus bump, more...
11 days ago
Eastman Kodak is making a fresh move to manufacturing drug ingredients with a $765 million government loan under the direction of President Trump.
12 days ago
Spectrum Pharmaceuticals announced good news for lung cancer patients in its midstage trial on Tuesday.
13 days ago
Credit Suisse has assembled its favorite health care recovery stocks for a recovering base of elective surgeries and for the risk of rising hospitalizations that go well beyond COVID-19.
13 days ago
Pfizer released a better than expected second-quarter earnings report and increased its guidance before the markets opened on Tuesday.
13 days ago
Pfizer and BioNTech made another big step in their fight against COVID-19 by initiating their late-stage study for their lead mRNA vaccine candidate.
13 days ago
MediciNova saw the coronavirus bump on Monday after it said it had entered a worldwide exclusive agreement with BioComo for the rights to develop a SARS-CoV-2 vaccine.
13 days ago
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
14 days ago
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
16 days ago
Arbutus Biopharma stock has seen an incredible rise over the past few days after the firm won a patent dispute that could have implications for coronavirus vaccine frontrunner Moderna.
17 days ago
Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm thinks these stocks could go on the offensive for the rest of the year.
17 days ago
Last Updated: 17 days ago
Pfizer and BioNTech S.E. aim to begin delivering 300 million doses of their vaccine for COVID-19 in 2021, but in the meantime, these companies will get a nice payoff.
19 days ago
The current focus on controlling the COVID-19 pandemic, companies that provide other health care products and services have received less attention from investors and analysts. Here are seven that...
19 days ago
Last Updated: 19 days ago